Mannkind reported $1.25B in Market Capitalization this December of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adma Biologics ADMA:US USD 478M 89M
Biocryst Pharmaceuticals BCRX:US USD 2.34B 376M
Dynavax Technologies DVAX:US USD 1.32B 270M
Eli Lilly And LLY:US USD 307.24B 831M
Halozyme Therapeutics HALO:US USD 5.45B 622M
Immunogen IMGN:US USD 1.06B 63M
Insmed INSM:US USD 2.62B 258M
Karyopharm Therapeutics KPTI:US USD 442M 82M
Macrogenics MGNX:US USD 213M 32M
Mannkind MNKD:US USD 813M 149M
Merk MRK:US USD 218.17B 12.39B
Minerva Neurosciences NERV:US USD 49M 31M
Novavax NVAX:US USD 1.42B 2.6B
Novo Nordisk A Fs NVO:US DKK 174.95B 17.57B
Peregrine Pharmaceuticals PPHM:US USD 944M 314M
Pfizer PFE:US USD 245.6B 48.58B
Sanofi SAN:FP EUR 99.37B 22.52B
Xencor XNCR:US USD 1.55B 79M